TGM2 and metabolic dysfunction-associated steatotic liver disease: In an Italian study, the prevalence of silent CD in 59 consecutive patients with NAFLD was 3.4% [99], which suggested that screening with EMA is preferred to tTG antibodies since tTG positivity, in the absence of confirmatory anti-EMA antibodies, is not sufficient to perform diagnostic endoscopy.